Chondrosarcoma clinical trials
The registry lists 99 studies for Chondrosarcoma across more than 10 countries. 20 are recruiting or about to start. 33 of them are mainly about Chondrosarcoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its narrower condition Chondrosarcoma, Extraskeletal Myxoid too: 118 studies, 23 open.
Get an email when these change. Save the Chondrosarcoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Cancer Institute (NCI) (6) · Memorial Sloan Kettering Cancer Center (6) · Istituto Ortopedico Rizzoli (5) · Peking University People's Hospital (3) · SWOG Cancer Research Network (3) · M.D. Anderson Cancer Center (3) · Sarcoma Alliance for Research through Collaboration (2) · Eastern Cooperative Oncology Group (2)
What is being tested here
Drugs under test in Chondrosarcoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Regorafenib | 1 | 0 | 2 |
| Enasidenib | 1 | 0 | 2 |
| Abemaciclib | 1 | 0 | 1 |
| Trabectedin | 1 | 0 | 1 |
| Doxorubicin | 0 | 1 | 3 |
| Ifosfamide | 0 | 1 | 3 |
| Docetaxel | 0 | 0 | 3 |
| Ivosidenib | 0 | 0 | 2 |
| Nivolumab | 0 | 0 | 2 |
| Celecoxib | 0 | 0 | 2 |
Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open · Immune checkpoint inhibitors 1 open · Alkylating agents 4 · Antimetabolites 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 10
- Dec 2026A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors · EpicentRx, Inc.
- Dec 2026Long-Term Longitudinal QoL in Patients Undergoing EEA · Ohio State University
- Dec 2026Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery · Istituto Ortopedico Rizzoli
- Feb 2027Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas · Memorial Sloan Kettering Cancer Center
- Mar 2027AG-120 in People With IDH1 Mutant Chondrosarcoma · Memorial Sloan Kettering Cancer Center
- Apr 2027A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning · Ricoh USA, Inc.
- May 2027Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base · Quironsalud
- Jun 2027Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration · Medical College of Wisconsin
- Jun 2027High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull · Massachusetts General Hospital
- Aug 2027Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone · Mayo Clinic
Who these studies take
Of the 18 Chondrosarcoma studies recruiting now, 12 (67%) set no upper age limit and 1 (6%) stop at 75 or younger. 8 (44%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (17%) | 3 (17%) |
| 18 | 17 (94%) | 17 (94%) |
| 30 | 17 (94%) | 17 (94%) |
| 40 | 17 (94%) | 17 (94%) |
| 50 | 18 (100%) | 18 (100%) |
| 65 | 18 (100%) | 18 (100%) |
| 75 | 18 (100%) | 18 (100%) |
| 85 | 17 (94%) | 17 (94%) |
Across all 99 studies, recruiting or not: 11% stop at 75 or younger and 8% at 65; 34% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 99. Browse all 99 → or search them.
- Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsRecruitingNCT06176989Phase 21 country
- Clinical Applicability of Liquid Biopsy in ChondrosarcomaRecruitingNCT074928231 country
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsRecruitingNCT05039801Phase 11 country
- Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic SequencingRecruitingNCT067493661 country
- Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway AlterationRecruitingNCT04040205Phase 21 country
- Assessment of Healing and Function After Reconstruction Surgery for Bone SarcomasRecruitingNCT034424651 country
- Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the BoneRecruitingNCT050332881 country
- BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastAvailableNCT040912951 country
- Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasRecruitingNCT04055220Not applicable1 country
- A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative PlanningRecruitingNCT06387485Not applicable1 country
- Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage SurgeryRecruitingNCT057796701 country
- Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull BaseRecruitingNCT05861245Not applicable1 country
- Diagnostic and Therapeutic Targets in Cartilaginous TumoursRecruitingNCT073155421 country
- PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 11 country
- Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton TherapyRecruitingNCT06029218Not applicable1 country
- Image Assisted Optimization of Proton Radiation Therapy in Chordomas and ChondrosarcomasRecruitingNCT048326201 country
- Understanding Engagement Trends in Chondrosarcoma Clinical TrialsNot yet recruitingNCT060294781 country
- Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic SarcomasRecruitingNCT05131386Phase 21 country
- A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade ChondrosarcomaRecruitingNCT05193188Phase 21 country
- Neutrophils in Bone SarcomasRecruitingNCT048674211 country
- Clear Cell Chondrosarcoma in ItalyActive, not recruitingNCT07360964Not applicable1 country
- High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of SkullActive, not recruitingNCT01346124Not applicable1 country
- Proton Beam Therapy for ChondrosarcomaActive, not recruitingNCT00496522Phase 21 country
- Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional ChondrosarcomaActive, not recruitingNCT04340843Phase 21 country
- Vismodegib in Treating Patients With Advanced ChondrosarcomasActive, not recruitingNCT01267955Phase 21 country
- Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsActive, not recruitingNCT04521686Phase 19 countries
- A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone SarcomasCompletedNCT02389244Phase 21 country
- Study of INBRX-109 in Conventional ChondrosarcomaActive, not recruitingNCT04950075Phase 29 countries
- Tazemetostat Expanded Access Program for Adults With Solid TumorsNo longer availableNCT03874455
- A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid TumorsActive, not recruitingNCT04673942Phase 21 country
- Long-Term Longitudinal QoL in Patients Undergoing EEAActive, not recruitingNCT040879021 country
- AG-120 in People With IDH1 Mutant ChondrosarcomaActive, not recruitingNCT04278781Phase 21 country
- Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 MutationCompletedNCT02073994Phase 12 countries
- Proton Radiation for Chordomas and ChondrosarcomasCompletedNCT01449149Not applicable1 country
- Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b TrialActive, not recruitingNCT03173976Phase 11 country
- Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILECompletedNCT065359971 country
- Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersTerminatedNCT04553692Phase 15 countries
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT040284791 country
- Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs ResectionCompletedNCT067147731 country
- Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesCompletedNCT03474640Phase 11 country
- Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasCompletedNCT03277924Phase 1/23 countries
- Itacitinib in Treating Patients With Refractory Metastatic/Advanced SarcomasTerminatedNCT03670069Phase 11 country
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 21 country
- Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRICompletedNCT01336803Phase 21 country
- Imatinib in Patients With Desmoid Tumor and ChondrosarcomaCompletedNCT00928525Phase 21 country
- YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic SarcomaActive, not recruitingNCT05448820Phase 1/21 country
- Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaCompletedNCT00003308Phase 24 countries
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic ChondrosarcomaCompletedNCT01330966Phase 22 countries
- A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)TerminatedNCT00543712Phase 22 countries
- Periosteal Chondrosarcoma: a Single Institution ExperienceCompletedNCT055118831 country